Unholy alliance? Dolo 650 maker gave Rs 1000 crore worth freebies to doctors, alleges Income Tax department

Published On 2022-07-16 06:08 GMT   |   Update On 2022-07-16 06:08 GMT
Advertisement

The series of Income Tax raids on makers of pharma company Micro Labs, seems to have opened a can of worms exposing the unholy alliance of bribery between pharma companies and doctors in the country, with the department now pointing out that the pharma company gave out freebies amounting to about Rs 1000 crores to doctors and medical professionals

The CBDT on Wednesday accused the makers of the widely-known Dolo-650 medicine tablet of indulging in "unethical practices" and distributing freebies of about Rs 1,000 crore to doctors and medical professionals in exchange for promoting products made by the pharmaceutical group.

For more details, check out the full story on the link below:

Unholy Alliance? Dolo 650 Maker Gave Rs 1000 Crore Worth Freebies To Doctors, Alleges Income Tax Department

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News